AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Celularity Inc Director's Dealing 2021

Jul 23, 2021

34506_dirs_2021-07-23_6290821d-b806-4c13-bc9d-c87536e4e9f0.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Celularity Inc (CELU)
CIK: 0001752828
Period of Report: 2021-07-16

Reporting Person: Sorrento Therapeutics, Inc. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Class A Common Stock	20422124	Direct